Latest & greatest articles for sertraline

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on sertraline or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on sertraline and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for sertraline

1. Sertraline

Sertraline Top results for sertraline - Trip Database or use your Google+ account Turning Research Into Practice My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for sertraline The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

2. The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial

The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir November 2017, Volume: 9, Issue: 11, Pages: 5770-5777, DOI: http://dx.doi.org/10.19082/5770 Corresponding author: Dr. Hosein Fahimi, Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, Iran. Tel: +98.3155540021; Email: hossein1fahimi (...) -commercial and no modifications or adaptations are made. Page 5770 The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial Zahra Sepehrmanesh 1 , Hosein Fahimi 2 , Goudarz Akasheh 3 , Mohamadreza Davoudi 4 , Hamidreza Gilasi 5 , Amir Ghaderi 6 1 M.D, Psychiatrist, Associate Professor, Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, Iran 2 M.D, Psychiatrist

Electronic physician2017 Full Text: Link to full Text with Trip Pro

3. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.

Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. Importance: Major depressive disorder (MDD) is prevalent among patients with chronic kidney disease (CKD) and is associated with morbidity and mortality. The efficacy and adverse events of selective serotonin reuptake inhibitors in these patients are unknown. Objective: To determine whether treatment with sertraline improves depressive symptoms (...) in patients with CKD and MDD. Design, Setting, and Participants: The Chronic Kidney Disease Antidepressant Sertraline Trial (CAST) was a randomized, double-blind, placebo-controlled trial involving 201 patients with stage 3, 4, or 5 non-dialysis-dependent CKD, who were enrolled at 3 US medical centers. The Mini Neuropsychiatric Interview was used to establish MDD. The first participant was randomized in March 2010 and the last clinic visit occurred in November 2016. Interventions: After a 1-week placebo

JAMA2017

4. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological

Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity

NIHR HTA programme2017

5. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological

Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity (...) psychological treatments as defined by the National Institute for Health and Care Excellence guidelines Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines Buszewicz M, Cape J, Serfaty M, Shafran R, Kabir T, Tyrer P

Health Technology Assessment (HTA) Database.2017

6. Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial.

Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial. 27626622 2016 09 14 2017 05 01 2017 05 01 2168-6238 73 10 2016 Oct 01 JAMA psychiatry JAMA Psychiatry Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial. 1041-1047 10.1001/jamapsychiatry.2016.2189 Prevention is more effective than treatment to decrease the burden of significant medical conditions such as depressive disorders, a major cause (...) of disability worldwide. Traumatic brain injury (TBI) is a candidate for selective strategies to prevent depression given the incidence, prevalence, and functional effect of depression that occurs after TBI. To assess the efficacy of sertraline treatment in preventing depressive disorders following TBI. A double-blind, placebo-controlled, parallel-group randomized clinical trial was conducted at a university hospital from July 3, 2008, to September 17, 2012, with 24 weeks of follow-up. A consecutive sample

EvidenceUpdates2016

7. Pharmacological interventions: Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60?years?

Pharmacological interventions: Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60?years? Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60 years? | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60 years? Article Text Further commentaries Electronic pages Pharmacological interventions Are sertraline, paroxetine

Evidence-Based Mental Health2016

8. Sertraline use during pregnancy and the risk of major malformations

Sertraline use during pregnancy and the risk of major malformations 25637841 2015 06 05 2015 08 20 2015 06 05 1097-6868 212 6 2015 Jun American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Sertraline use during pregnancy and the risk of major malformations. 795.e1-795.e12 10.1016/j.ajog.2015.01.034 S0002-9378(15)00090-3 Given the current debate and growing public concerns on selective serotonin reuptake inhibitors (SSRIs) and birth defects generated by Food and Drug (...) Administration warnings, we aim to quantify the association between first-trimester exposure to sertraline, a first-line treatment, and the risk of congenital malformations in a cohort of depressed women. This was a population-based cohort study in Quebec, Canada, 1998 through 2010. From a cohort of 18,493 depressed/anxious pregnancies, sertraline-exposed, nonsertraline SSRI-exposed, non-SSRI exposed, and unexposed (reference category) women were studied. Major malformations overall and organ-specific

EvidenceUpdates2015

9. Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline

Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline Article Text Pharmacological interventions Longer term outcomes need

Evidence-Based Mental Health2014

10. Sertraline

Sertraline USE OF SERTRALINE IN PREGNANCY 0344 892 0909 USE OF SERTRALINE IN PREGNANCY (Date of issue: January 2017 , Version: 2.2 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Sertraline is a selective serotonin reuptake inhibitor (SSRI) used (...) in the treatment of depression, obsessive-compulsive disorder, post-traumatic stress disorder, social anxiety disorder and panic disorder with or without agoraphobia. Data on the risk of congenital malformations following sertraline use in early pregnancy are conflicting. The majority of individual studies and two meta-analyses demonstrate no statistically significant increase in the overall risk of any malformation or of cardiovascular malformations following first trimester exposure. However

UK Teratology Information Service2014

11. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial

Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, O'Brien J (...) , Poppe M, Thomas A, Walwyn R, Wilson K, Banerjee S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of sertraline and mirtazapine, for the treatment of depression, in patients

NHS Economic Evaluation Database.2013

12. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial

The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial 23389323 2013 04 04 2013 05 31 2013 12 13 2168-6238 70 4 2013 Apr JAMA psychiatry JAMA Psychiatry The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. 383-91 10.1001/2013.jamapsychiatry.32 Transcranial direct current stimulation (tDCS) trials for major depressive (...) disorder (MDD) have shown positive but mixed results. To assess the combined safety and efficacy of tDCS vs a common pharmacological treatment (sertraline hydrochloride, 50 mg/d). Double-blind, controlled trial. Participants were randomized using a 2 × 2 factorial design to sertraline/placebo and active/sham tDCS. Outpatient, single-center academic setting in São Paulo, Brazil. One hundred twenty antidepressant-free patients with moderate to severe, nonpsychotic, unipolar MDD. Six-week treatment of 2

EvidenceUpdates2013

13. Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine Journals Library An error has

NIHR HTA programme2013

14. Sertraline effective for acute major depression

Sertraline effective for acute major depression PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They are funded by the New Zealand Guidelines Group. PEARLS provide guidance on whether a treatment is effective or ineffective. PEARLS are prepared as an educational resource and do not replace clinician judgement in the management of individual cases. View PEARLS online at: www.cochraneprimarycare.org (...) Sertraline effective for acute major depression Clinical question How effective is sertraline (escitalopram) in the acute phase treatment of major depression? Bottom line There was evidence favouring sertraline over some other antidepressants for the acute phase treatment of major depression, in terms of efficacy, compared with fluoxetine, (NNT* 10; range, 6 to 14) or acceptability/tolerability, compared with amitriptyline, imipramine, paroxetine and mirtazapine. Follow-up was limited to 24 weeks

Cochrane PEARLS2012

15. Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression

Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression Article Text Aetiology Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression

Evidence-Based Mental Health2012

16. Sertraline and mirtazapine do not reduce severity of depression in people with dementia

Sertraline and mirtazapine do not reduce severity of depression in people with dementia Sertraline and mirtazapine do not reduce severity of depression in people with dementia | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Sertraline and mirtazapine do not reduce severity of depression in people with dementia Article Text Therapeutics Sertraline and mirtazapine do not reduce severity of depression in people with dementia Statistics from Altmetric.com No Altmetric data available for this article. Question Question Are the two most commonly

Evidence-Based Mental Health2012

17. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. 21764118 2011 08 01 2011 08 11 2015 07 08 1474-547X 378 9789 2011 Jul 30 Lancet (London, England) Lancet Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. 403-11 10.1016/S0140-6736(11)60830-1 Depression is common in dementia but the evidence base for appropriate drug treatment (...) is sparse and equivocal. We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo. We undertook the parallel-group, double-blind, placebo-controlled, Health Technology Assessment Study of the Use of Antidepressants for Depression in Dementia (HTA-SADD) trial in participants from old-age psychiatry services in nine centres in England. Participants were eligible if they had probable or possible Alzheimer's disease, depression

Lancet2011

18. Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy

Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy Article Text Aetiology Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy Statistics from

Evidence-Based Mental Health2010

19. Short term CBT and sertraline, alone or in combination, reduce anxiety in children and adolescents

Short term CBT and sertraline, alone or in combination, reduce anxiety in children and adolescents Short term CBT and sertraline, alone or in combination, reduce anxiety in children and adolescents | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Short term CBT and sertraline, alone or in combination, reduce anxiety in children and adolescents Article Text Therapeutics Short term CBT and sertraline, alone or in combination, reduce anxiety in children and adolescents Statistics from Altmetric.com No Altmetric data available for this article. QUESTION

Evidence-Based Mental Health2009

20. A combination of cognitive?behavioural therapy and sertraline reduced anxiety in children more than either treatment alone

A combination of cognitive?behavioural therapy and sertraline reduced anxiety in children more than either treatment alone A combination of cognitive–behavioural therapy and sertraline reduced anxiety in children more than either treatment alone | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A combination of cognitive–behavioural therapy and sertraline reduced anxiety in children more than either treatment alone Article Text Therapeutics A combination of cognitive–behavioural therapy and sertraline reduced anxiety in children more than either

Evidence-Based Medicine (Requires free registration)2009